|
Market Cap (17-May) $737,823,936 (475th) |
Close (30-Jun) $0.056 |
Volume (30-Jun) 1,984,515 |
Shortsold (5-May) 771,706 (0.13%) (409th) |
|
52w High $2.09 |
52w Low $0.90 |
P/E - |
EPS -0.11 |
PYC released this announcement to the ASX on 26 April 2023, 8:58. The announcement is marked as price sensitive, and is 3 page(s) in length and 249.84kb in size.
You can view all announcements from PYC and see how they appear on a price chart on the announcements page.
At the date of this announcement, PYC was 0.000% short sold according to ASIC data. It was ranked the 645th most shorted stock on the ASX. It is now ranked as the 409th most shorted stock on the ASX with 0.132% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from PYC | |
|---|---|
| FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL | 30 June 2023, 8:17 |
| Change of Director's Interest Notice | 28 June 2023, 16:46 |
| PYC Investor Update Presentation | 16 June 2023, 8:32 |
| Commencement of First Clinical Study in RP11 | 26 April 2023, 8:58 |
| PYC BIO 2023 Presentation | 19 April 2023, 9:18 |
| Second Drug Program Progressing to Human Trials | 3 April 2023, 9:54 |
| Cleansing Notice Under Section 708AA | 7 March 2023, 19:52 |
You must be logged in to post a reply.
